Keros Therapeutics, Inc.

KROS · Pharmaceutical Preparations
7
Directors
64
Avg Age
5.4
Avg Tenure (yrs)
86%
Independent
Independent Non-independent Near rotation

Board Members

JB
Jean-Jacques Bienaimé Chair
JP
Jasbir Seehra, Ph.D. Director

2 directors with 10+ years of tenure.

...and 5 more directors

The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.

Get Seats Opening

Source: SEC DEF 14A proxy statement filed 2026-04-22. Data extracted and structured by FindABoardSeat.